1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsCommunity Health Promotion and Disease Prevention Program is sponsored by National Institutes of Health (NIH). Supports research on community-based health promotion and disease prevention strategies.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Office of Disease Prevention (ODP) | Grants & Funding U.S. Department of Health and Human Services National Institutes of Health Office of Disease Prevention (ODP) ODP Policy Considerations Additional Information by Funding Category The mission of the Office of Disease Prevention (ODP) is to improve public health by increasing the scope, quality, dissemination, and impact of prevention research supported by the National Institutes of Health (NIH).
Prevention is preferable to treatment and prevention research is an important part of NIH's mission. The knowledge gained leads to stronger clinical practice, health policy, and community health programs.
ODP’s work focuses on primary and secondary prevention research in humans, including research that seeks to: Identify risk and protective factors Screen and identify people who are at risk for or have signs of an early-stage condition Develop and evaluate interventions to promote health, enhance protective factors, reduce risk factors, or address environmental and contextual drivers Evaluate the impact of policies and regulations designed to promote health and safety Test implementation and dissemination strategies for evidence-based preventive interventions and practices Develop and evaluate rigorous research methods and measures for prevention research studies Evaluate the economics of prevention ODP prioritizes projects that test interventions to address the leading risk factors associated with mortality, chronic conditions and other morbidities in the United States: injury and violence (includes self-harm) ODP also puts a high priority on prevention projects that aim to reduce health disparities, address social determinants of health, promote implementation research, and advance workforce development and research capacity building.
ODP coordinates and co-funds collaborative NIH research and activities to advance research to address gaps identified by the Community Preventive Services Task Force , the U.S. Preventive Services Task Force , Healthy People 2030 , and NIH Pathways to Prevention (P2P) workshops . Highlighted Topics identify timely or emerging research priorities across one or more NIH Institutes, Centers, or Offices (ICOs).
Use Parent Announcements or other broad NIH opportunities to submit investigator-initiated applications on a topic. While Highlighted Topics do not affect referral or review, some include dedicated funding. See the Highlighted Topic FAQs ODP Grant Funding Opportunity Notices in the NIH Guide for Grants and Contracts ODP Policy Considerations All NIH ICOs follow a set of NIH-wide policies .
These ICO-specific considerations build on those policies. ODP General Funding Policies Additional Information by Funding Category Administrative Supplements In addition to our Administrative Supplements overview, consider the following ODP-specific information.
Administrative Supplement Interest Areas: ODP will consider co-funding administrative supplements if the supplement request is consistent with current NIH guidance; the ICO administering the parent award agrees to accept it for consideration; and the supplement is relevant to the ODP mission. Requests for co-funding administrative supplements are submitted to ODP by ICO program staff.
Requests sent directly to ODP from investigators will not be considered. Office of Disease Prevention (ODP) Just getting started and want to discuss your research idea? Use Matchmaker to find relevant NIH program officials.
Enter your draft specific aims, abstract, or other scientific text and choose the "Similar Program Officials" option. The search results list matching funding ICOs and NIH program officials. Reach out to best match first, and don't worry if it's not a perfect fit.
They can direct you to who is. Learn more in the Matchmaker Tool Video Tutorial . Already applied or received an award?
Reach out to the contacts listed in the Status section of eRA Commons for your application or award. Still not sure who to talk to? Use the email addresses listed in each of the funding category sections above.
For technical issues E-mail OER Webmaster
According to the current listing, eligibility includes: Nonprofit organizations, public or private universities, and state or local governments. Confirm the full requirements in the official notice before applying.
Community Health Promotion and Disease Prevention Program is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article